Presence or absence of intestinal metaplasia but not its burden is associated with prevalent high-grade dysplasia and cancer in Barrett's esophagus

Diseases of the Esophagus

Volumn 27, Issue 8, 2014, Pages 751-756

  Bansal, A ^a   Mcgregor, D H ^b   Anand, O ^a   Singh, M ^a   Rao, D ^a   Cherian, R ^b   Wani, S B ^a   Rastogi, A ^a   Singh, V ^a   House, J ^c   Jones, P G ^c   Sharma, P ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

Barrett's esophagus; Columnar lined esophagus; Dysplasia; Esophageal adenocarcinoma; Goblet cell density; Intestinal metaplasia

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; CAUCASIAN; CELL DENSITY; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; ESOPHAGUS DYSPLASIA; FEMALE; GOBLET CELL; HIATUS HERNIA; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SYSTEMATIZED NOMENCLATURE OF MEDICINE; ADENOCARCINOMA; AGED; COMPLICATION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; INTESTINE; METAPLASIA; MIDDLE AGED; PATHOLOGY; PREVALENCE;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GOBLET CELLS; HUMANS; INTESTINES; MALE; METAPLASIA; MIDDLE AGED; PREVALENCE;

EID: 84925945958     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12151     Document Type: Article

References (34)

1. Barrett N R. Chronic peptic ulcer of the oesophagus and 'oesophagitis'. Br J Surg 1950; 38 (150): 175-182.
2. Pohl H, Welch H G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 142-146.
3. Sharma P, McQuaid K, Dent J etal. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004; 127: 310-330.
4. Wang K K, Sampliner R E. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008; 103: 788-797.
5. Playford R J, British N. Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus. Gut 2006; 55: 442. doi: 10.1136/gut.2005.083600.
6. Ogiya K, Kawano T, Ito E etal. Lower esophageal palisade vessels and the definition of Barrett's esophagus. Dis Esophagus 2008; 21: 645-649.
7. Haggitt R C, Tryzelaar J, Ellis F H, Colcher H. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol 1978; 70: 1-5.
8. Hamilton S R, Smith R R. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987; 87: 301-312.
9. Skinner D B, Walther B C, Riddell R H, Schmidt H, Iascone C, DeMeester T R. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg 1983; 198: 554-565.
10. Thompson J J, Zinsser K R, Enterline H T. Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction. Hum Pathol 1983; 14: 42-61.
11. Gatenby P A, Ramus J R, Caygill C P, Shepherd N A, Watson A. Relevance of the detection of intestinal metaplasia in non-dysplastic columnar-lined oesophagus. Scand J Gastroenterol 2008; 43: 524-530.
12. Kelty C J, Gough M D, Van Wyk Q, Stephenson T J, Ackroyd R. Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk. Scand J Gastroenterol 2007; 42: 1271-1274.
13. Takubo K, Aida J, Naomoto Y etal. Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum Pathol 2009; 40: 65-74.
14. Chandrasoma P T, Der R, Dalton P etal. Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol 2001; 25: 1188-1193.
15. Sharma P, Falk G W, Weston A P, Reker D, Johnston M, Sampliner R E. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006; 4: 566-572.
16. Montgomery E, Bronner M P, Goldblum J R etal. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001; 32: 368-378.
17. Odze R D. Diagnosis and grading of dysplasia in Barrett's oesophagus. J Clin Pathol 2006; 59: 1029-1038.
18. Reid B J, Haggitt R C, Rubin C E etal. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988; 19: 166-178.
19. Sharma P. Clinical practice. Barrett's esophagus. N Engl J Med 2009; 361: 2548-2556.
20. Cameron A J, Lomboy C T, Pera M, Carpenter H A. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995; 109: 1541-1546.
21. Harrison R, Perry I, Haddadin W etal. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol 2007; 102: 1154-1161.
22. Oberg S, Johansson J, Wenner J etal. Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery. Ann Surg 2001; 234: 619-626.
23. Bhat S, Coleman H G, Yousef F etal. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst 2011; 103: 1049-1057.
24. Jung K W, Talley N J, Romero Y etal. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study. Am J Gastroenterol 2011; 106: 1447-1455. quiz 1456.
25. Westerhoff M, Hovan L, Lee C, Hart J. Effects of dropping the requirement for goblet cells from the diagnosis of Barrett's esophagus. Clin Gastroenterol Hepatol 2012; 10: 1232-1236.
26. Chaves P, Crespo M, Ribeiro C etal. Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved. Mod Pathol 2007; 20: 788-796.
27. Romagnoli S, Roncalli M, Graziani D etal. Molecular alterations of Barrett's esophagus on microdissected endoscopic biopsies. Lab Invest 2001; 81: 241-247.
28. Liu W, Hahn H, Odze R D, Goyal R K. Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. Am J Gastroenterol 2009; 104: 816-824.
29. Knudson A G. Two genetic hits (more or less) to cancer. Nat Rev Cancer 2001; 1: 157-162.
30. Nowak M A, Komarova N L, Sengupta A etal. The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci U S A 2002; 99: 16226-16231.
31. Vieth M, Barr H. Editorial: defining a bad Barrett's segment: is it dependent on goblet cells? Am J Gastroenterol 2009; 104: 825-827.
32. Spechler S J. Barrett's esophagus: is the goblet half empty? Clin Gastroenterol Hepatol 2012; 10: 1237-1238.
33. Hahn H P, Blount P L, Ayub K etal. Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus. Am J Surg Pathol 2009; 33: 1006-1015.
34. Srivastava A, Odze R D, Lauwers G Y, Redston M, Antonioli D A, Glickman J N. Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia. Am J Surg Pathol 2007; 31: 1733-1741.